Jonathan Rothbard, PhD.
Dr. Rothbard was a co-founder of CellGate and served as CellGate's Chief Scientific Officer, overseeing exploratory research efforts and investigating new directions for CellGate's technology development. Earlier, Dr. Rothbard was a Senior Director of ImmuLogic Corporation and the head of the laboratory of molecular immunology at the Imperial Cancer Research Fund in London. He received his Ph.D. in organic chemistry from Columbia University and completed a postdoctoral fellowship at The Rockefeller University. He has over 100 publications in the fields of chemistry biochemistry and immunology. Dr. Rothbard is an inventor of the use of oligo-L-arginines for the prevention of stenosis.